Bioequivalence and intrasubject variability
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 1 (2) , 205-219
- https://doi.org/10.1080/10543409108835019
Abstract
Bioequivalence of the two formulations refers to the equivalence of the marginal distributions of the two formulations. Under normal assumptions, this would require the equivalence of both average and intrasubject variability of bioavailability. A procedure is introduced for the equivalence in intrasubject variability for bioavailability/ bioequivalence studies with the standard two-by-two crossover design. It is shown that the confidence interval approach is operationally identical to the hypothesis testing in assessment of equivalence of intrasubject variability. A hypothetical data set from a two-by-two crossover bioequivalence study illustrates the procedure.Keywords
This publication has 8 references indexed in Scilit:
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Design and Analysis of Cross-Over TrialsPublished by Taylor & Francis ,1989
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- A new procedure for testing equivalence in comparative bioavailability and other clinical trialsCommunications in Statistics - Theory and Methods, 1983
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982
- The Jackknife, the Bootstrap and Other Resampling PlansPublished by Society for Industrial & Applied Mathematics (SIAM) ,1982
- Statistical Simulation Study of New Proposed Uniformity Requirement for Bioequivalency StudiesJournal of Pharmaceutical Sciences, 1981
- An analysis of variance test for normality (complete samples)Biometrika, 1965